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A plasma membrane protein was found to contain antigenic determinants in common with a Pi-binding 
protein released by osmotic shock from Candida tropicalis. This plasma membrane protein (M.P. 30) has 
a molecular mass of 30 kDa as measured by SDS-PAGE and anti-M.P. 30 antibodies inhibit P, uptake 
in protoplasts while only the corresponding Fab fragments inhibit Pi transport in whole cells. This plasma 
membrane protein may be the P, plasma membrane carrier. 
Yeast Plasma membrane protein Antibody P, carrier 
1. INTRODUCTION 
High-affinity Pi transport activity in Candida 
tropicalis is drastically reduced by osmotic shock 
[l]. Characterization and partial purification of 
two Pi-binding proteins (Pi-binding protein 1 and 
Pi-binding protein 2) released by osmotic shock 
have been reported [2]. The inhibitory effect of 
antibodies raised against each of these proteins 
suggests that Pi-binding protein 2 (PiBP2) is in- 
volved in Pi uptake at physiological pH values [3]. 
The release of this protein during protoplast for- 
mation is accompanied by a marked change in the 
Km values of Pi uptake increasing from 5-6pM in 
whole cells to 400-500,uM in protoplasts [4]. The 
high-affinity Pi transport system is thought to be 
composed of a Pi-binding protein (located near 
the cell surface within the cell wall) and a Pi- 
specific plasma membrane carrier. Unpublished 
data showed that antigenic determinants recognized 
by anti-PiBP2 antibodies were present at a very low 
level in protoplasts. We report here the isolation by 
an immunoadsorbent column of two membrane- 
bound proteins bearing the same antigenic deter- 
minant(s) as PiBP2. One has the same molecular 
mass as PiBP2 and may be a membranous form of 
PiBP2; the second one has a molecular mass of 
30 kDa. Antibodies raised against the 30 kDa pro- 
tein inhibit Pi uptake by protoplasts and the cor- 
responding Fab fragments inhibit Pi uptake by 
whole cells. These results suggest that the 30 kDa 
plasma membrane protein is the Pi-specific plasma 
membrane carrier in C. tropicalis. 
2. MATERIALS AND METHODS 
2.1. Strain and growth conditions 
C.tropicaiis (CBS 6947) was grown and Pi- 
starved as in [ 11. Cells were osmotically shocked as 
in [2,3]. Proteins present in the shock fluid were 
purified as in [2,3]. 
2.2. Immunoadsorbent column 
Anti-PiBP2 antibodies (in 0.25 M Na-carbonate 
buffer, pH 8.5) were coupled to Sepharose 4B CN 
(Pharmacia) as in [5,6]. 
Abbreviation: SDS-PAGE, SDS-polyacrylamide gel 2.3. SDS-PAGE 
electrophoresis SDS-PAGE was performed as in [7]. 
Published by Elsevier Science Publishers B. V, 
00145793/84/$3.00 @ 1984 Federation f European Biochemical Societies 83 
Volume 165, number 1 FEBS LETTERS January 1984 
2.4. Purification of plasma membrane proteins 
Pi-starved and osmotically shocked C. tropicalis 
cells were disrupted with a French press and the 
plasma membranes purified as in [8,9]. The plasma 
membrane proteins (10 mg .ml-‘) were solubilized 
in the presence of 2.5% Triton X-100, 20mM 
Tris-HCl (pH 8.0), 0.05% NaN3, and 10T4M 
PMSF. The Triton concentration was then lowered 
to 0.5~0 in the same buffer and the plasma mem- 
branes were centrifuged (40~ x g, 1 h). The 
pellet was discarded. The supernatant fraction 
(protein mixture) was applied to a Sepharose 
4B CN column coupled with control immuno- 
globulins, equilibrated with binding buffer (0.5% 
Triton X-100, 20 mM Tris-HCI (pH 8) and 0.05~0 
NaN3). The sample was recycled through the col- 
umn continuously for 4 h at 4°C. The non-bound 
fraction was applied to a Sepharose 4B CN column 
coupled with anti-PiBP2 antibodies and recycled 
through the column continuously at 4°C in binding 
buffer overnight. Proteins specifically retained 
were eluted with 50mM diethylamine (pH 11.5), 
0.5% Triton X-100, and immediately neutralized 
with 0.36M Tris-acetate (pH 5.0). The proteins 
were dialyzed, concentrated on an Amicon mem- 
brane filter (Minicon concentrator Bl5) and sus- 
pended in 20 mM Tris-HCl (pH 8.0), 0.5% Triton 
X-100, 0.05% NaN3, prior to SDS-PAGE. Pro- 
tein concentration was determined as in [lo]. 
2.5. Preparation of a~ti~er~rn 
The plasma membrane proteins specifically re- 
tained by the immunoadsorbent column (anti- 
PiBP2 antibodies) were analyzed by SDS-PAGE. 
The band corresponding to the 30 kDa protein was 
cut out and homogenized in Na-phosphate buffer 
(0.1 M, pH 8.0) in a Potter homogenizer. The 
homogenates (30-5Opg protein) were mixed with 
Freund’s adjuvant and injected subcutaneously 
into a male New Zealand rabbit. Two booster 
injections of the same mixture were made, 1 and 2 
months later. Ten days after the last injection, the 
rabbit was bled. The antiserum was clarified by 
centrifugation and kept in the freezer (-20°C). 
Antibodies were precipitated with (NH4)2S04 (40% 
saturation), dialyzed overnight, concentrated in 
10 mM Na-phosphate buffer (pH 8.0), 0.4% NaN3, 
and chromatographed on a DEAE-Sephacel col- 
umn (Pharmacia) in the same buffer. Antibodies 
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were collected in the void volume and used as 
follows: 
Before uptake experiments using whole cells, the 
antibodies were dialyzed, concentrated, and sus- 
pended in a 50 mM Mes-KOH buffer (pH6.5). 
When experiments were run with protoplasts, the 
buffer contained 0.82 M sorbitol. Immunoglobu- 
lins from a control serum were treated similarly. 
The Fab fragments from the antibodies, pre- 
pared as in [ 1 I], were separated from Fc fragments 
by chromatography on a DEAE-Sephacel column. 
For uptake experiments the Fab fragments were 
pooled, dialyzed, concentrated in 50mM Mes- 
KOH buffer (pH6.5) and stored at -20°C. 
2.6. rmmunob~ott~~g 
Electrophoretic transfer of proteins from SDS- 
PAGE to nitrocellulose sheets was carried out as in 
]121. 
2.7. Pi uptake 
Protoplasts were prepared from Pi-starved cells 
as in [13,14]. Prior to Pi uptake, protoplasts were 
incubated with antibodies (18 mg for 25 mg proto- 
plast protein) or with control immunoglobulins for 
10 min at 32°C in Mes-KOH buffer (pH 6.5) con- 
taining 0.82M sorbitol. They were then diluted 
6-fold in pH 5.4 uptake medium (for composition 
see [4]) and gently shaken at 32°C. Five min later, 
Pi uptake was started by adding 32Pi at various 
concentrations. At 1, 3, 6, and lOmin, aliquots of 
0.4ml of the protoplast suspension were with- 
drawn and diluted in lOm1 of the cold uptake 
medium and centrifuged for 2 min at 6000 x g. The 
pellet was resuspended and sampled for protein de- 
termination and radioactivity. 
Conditions for Pi uptake by cells were as follows: 
5 x 106- IO7 PI-starved cells were pelleted and sus- 
pended in 0.3 ml of 50mM Mes-KOH buffer 
(pH 6.5) containing either immunoglobulins (1 mg), 
antibodies (1 mg) or Fab fragments (0.5 mg) and in- 
cubated at 32°C. After 20 min, the cell suspension 
was diluted IO&fold with uptake medium (50 mM 
Mes-KOH (pH 5.4), 0.5% glucose). After shaking 
for 5 min at 32”C, 2 ml of the cell suspension was 
injected into tubes containing 32Pi at various con- 
centrations. After a 30 s uptake period, the cells 
were filtered on a Sartorius membrane filter and 
rinsed with demineralized water. The radioactivity 
of the samples was measured. 
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3. RESULTS AND DISCUSSION 
3.1. Purification of two plasma membrane proteins 
by using an immunoadsorbent column 
Of the proteins released by osmotic treatment of 
C.tropicalis cells, only PiBP2 was specifically re- 
tained on an immunoadsorbent column coupled 
with anti-PiBP2 antibodies, as shown in fig. 1, lane 
a. Its molecular mass was 52 kDa as determined by 
SDS-PAGE and 60 kDa by gel filtration on Sepha- 
dex G-100. In an earlier paper [2], we reported 
making a PiBP2 preparation which was slightly 
contaminated and had a molecular mass of 70 kDa 
(determined by gel filtration). In contrast, when 
kd- 
kd- 
Fig. 1. Electrophoretic separation by SDS-PAGE of: Pi- 
binding protein 2 from the shock fluid after its specific 
retention on an immunoadsorbent column coupled with 
anti-PiBP2 antibodies (lane a); plasma membrane pro- 
teins specifically retained by the same immunoadsorbent 
Fig.2. (A) Autoradiograms of immunoblotted plasma 
membrane proteins. The plasma membrane proteins 
were solubilized in 1% SDS, separated by electrophoresis 
and transferred to nitrocellulose sheets. The binding of 
antibodies to the plasma membrane proteins was de- 
tected by “‘I-protein A. Two major bands correspon- 
ding to 52 kDa and 30 kDa (the latter being more 
intensely labelled) were revealed by autoradiography. 
Exposure time: 16 h. (B) Ouchterlony tests: well 1, pro- 
teins released by osmotic shock; well 2, anti-PiBP2 
antiserum; wells 3 and 4 anti-M.P. 30 antibodies. A 
precipitation line can only be observed between well 1 
and 2. There is no reaction of anti-M.P. 30 antibodies 
column (lane b). kd, kDa. with the proteins present in the shock fluid. 
solubilized plasma membrane proteins were loaded 
on the same immunoadsorbent column, two major 
polypeptides were specifically retained (fig. 1, lane 
b). One had the same molecular mass as PiBP2 
and may be a membranous form of PiBP2. The 
second one had a molecular mass of 30 kDa; it is 
obvious that this polypeptide shares some anti- 
genie determinants with the soluble and presum- 
ably membranous forms of PiBP2. Antiserum was 
generated against this plasma membrane protein 
(30 kDa, called M.P. 30) prepared as described in 
section 2. It recognized this polypeptide, and to a 
lesser extent, another one of 52 kDa (the putative 
membranous form of PiBP2) as shown by immuno- 
52 !kd 
30 kd 
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Fig.3. Inhibitory effect of whole anti-M.P. 30 antibodies and of the corresponding Fab fragments on the P, uptake by 
protoplasts (A) and by whole cells (B). (a---+) Control (in the presence of immunoglobulin), (o----o) whole anti- 
M.P. 30 antibodies, (s) Fab fragments prepared from anti-M.P. 30 antibodies. K: initial velocities are expressed 
in mol Piemg protein-’ emin- ’ for protoplasts (A) and in mol P,*cell-’ absorbed in 30 s for whole cells (B) C: molar 
Pi concentration. 
blotting (fig.2A). Ouchterlony tests (fig.28) showed 
that anti-M.P. 30 antiserum does not recognize the 
soluble form of PiBP2 present in the shock fluid. 
3.2. Effects on Pi uptake of anti4f.P. 30 anti- 
bodies and of their derived Fab fragments 
The M.P. 30 antibodies inhibited Pi uptake by 
protoplasts (fig.3A) but not that by whole cells 
(fig.3B); however, Fab fragments prepared from 
the anti-M.P. 30 antibodies were effective in in- 
hibiting Pi uptake by whole cells (fig.3B). Thus, it 
seems likely that while whole antibody molecules 
cannot enter and move through the cell wall to 
bind the plasma membrane protein, in the absence 
of cell wall (i.e. in protoplasts), the whole anti- 
bodies can directly reach the M.P. 30. Presumably, 
the lower molecular mass of the derived anti- 
M.P. 30 Fab fragments is responsible for the in- 
creased penetration of the cell wall and binding of 
the plasma membrane protein at the plasma mem- 
brane level, as evidenced by the inhibition of Pi up- 
take in whole cells. It is suggested that the M.P. 30 
may be the membrane-specific Pi carrier in C. tropi- 
calis based on the differential activity of M.P. 30 
antibodies and their derived Fab fragments. The 
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results reported here lead us to propose the fol- 
lowing hypothesis: the high-affinity Pi transport 
system is composed of a Pi-binding protein, 
located near the cell surface within the cell wall and 
of a plasmalemma-specific Pi carrier of 30 kDa. 
This hypothesis is supported by the fact that Pi up- 
take in whole cells is equally inhibited by whole 
anti-PiBP2 antibody molecules as by their corres- 
ponding Fab fragments (not shown). Moreover, it 
should be pointed out that the molecular mass of 
this membrane-specific Pi carrier is close to that 
found for Pi carriers in mitochondria [ 15-181 and 
in chloroplasts [ 191. 
REFERENCES 
ill 
121 
131 
[41 
PI 
Blasco, F., Ducet, G. and Azoulay, E. (1976) Bio- 
chimie 58, 351-357. 
Jeanjean, R. and Fournier, N. (1979) FEBS Lett. 
105, 163-166. 
Jeanjean, R., Attia, A., Jarry, T. and ColK, A. 
(1981) FEBS Lett. 125, 67-71. 
Jeanjean, R., BtSdu, S., Attia, A. and Rocca-Serra, 
J. (1982) Biochimie 64, 75-78. 
Cuatrecasas, P. (1970) J. Biol. Chem. 245, 3059- 
3065. 
Volume 165, number 1 FEBS LETTERS January 1984 
[6] McMasters, W.R. and Williams, A.F. (1979) 
Immunol. Rev. 47, 117-137. 
[7] Laemmli, U.K. (1970) Nature 227, 681-685. 
[8] Blasco, F., Chapuis, J.P. and Giordani, R. (1981) 
Biochimie 63, 507-514. 
[9] Dufour, J.P. and Goffeau, A. (1978) J. Biol. 
Chem. 253, 7026-7032. 
[lo] Bradford, M.M. (1976) Anal. Biochem. 72, 248- 
254. 
[ll] Lifter, J. and Choi, Y.S. (1978) J. Immunol. 
Methods 23, 297-302. 
[12] Burnette, W.N. (1981) Anal. Biochem. 112, 195- 
203. 
[13] Theuvenet, A.P.R. and Bindels, R.J.M. (1980) 
Biochim. Biophys. Acta 599, 587-595. 
[14] Blasco, F., Gidrol, X. and Giordani, R. (1982) 
Arch. Microbial. 132, 317-321. 
[15] Hoffman, H.D. and Kadenbach, B. (1979) Eur. J. 
Biochem. 102, 605-613. 
[16] Wohlrab, H. (1979) Biochemistry 18, 2098-2102. 
[17] Kolbe, H.V.J., Bottrich, J., Genchi, G., Palmieri, 
F. and Kadenbach, B. (1981) FEBS Lett. 124, 
265-269. 
[18] Touraille, S., Briand, Y ., Durand, R., Bonnafous, 
J.C. and Mani, J.C. (1981) FEBS Lett. 128, 142- 
144. 
[19] Fliigge, U.I. (1982) FEBS Lett. 140, 273-276. 
87 
